About
209.86USD+2.08 +1.00%
Closed • Updated at 13:21 GMT+00:00Market Cap$30.44B
P/E Ratio20.23
Volume1.79M
Beta0.58
RSI46.50
Gross Margin60.74%
Resmed Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
Apr 30 2026
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
Apr 29 2026
Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - ResMed, Koninklijke Philips, and Carefusion
Apr 1 2026
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
Mar 3 2026
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
Translate